Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;79(11-12):1657–1664. doi: 10.1038/sj.bjc.6690265

Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations

J M Boyle 1, M J Greaves 1, R S Camplejohn 2, J M Birch 3, S A Roberts 4, J M Varley 1
PMCID: PMC2362814  PMID: 10206274

Abstract

Radiation-induced G1 arrest was studied in four classes of early passage skin fibroblasts comprising 12 normals, 12 heterozygous (mut/wt) TP53 mutation-carriers, two homozygous (mut/–) TP53 mutation-carriers and 16 strains from nine Li-Fraumeni syndrome or Li-Fraumeni-like families in which no TP53 mutation has been found, despite sequencing of all exons, exon–intron boundaries, 3′ and 5′ untranslated regions and promoter regions. In an assay of p53 allelic expression in yeast, cDNAs from these non-mutation strains behaved as wild-type p53. Using two different assays, we found G1 arrest was reduced in heterozygous strains with mis-sense mutations and one truncation mutation, when compared to the range established for the normal cells. Heterozygous strains with mutations at splice sites behaved like normal cells, whilst homozygous (mut/–) strains showed either extremely reduced, or no, arrest. Strains from all nine non-mutation families gave responses within the normal range. Exceptions to the previously reported inverse correlation between G1 arrest and clonogenic radiation resistance were observed, indicating that these phenotypes are not strictly interdependent. © 1999 Cancer Research Campaign

Keywords: Li-Fraumeni syndrome, G1 arrest, cell cycle, fibroblasts, radiosensitivity, p53

Full Text

The Full Text of this article is available as a PDF (158.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. M., Hanby A. M., Gillett C. E., Mohammed S., Hodgson S., Bobrow L. G., Leigh I. M., Purkis T., MacGeoch C., Spurr N. K. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet. 1992 Aug 1;340(8814):259–263. doi: 10.1016/0140-6736(92)92354-i. [DOI] [PubMed] [Google Scholar]
  2. Bian J., Sun Y. p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family? Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14753–14758. doi: 10.1073/pnas.94.26.14753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birch J. M., Hartley A. L., Tricker K. J., Prosser J., Condie A., Kelsey A. M., Harris M., Jones P. H., Binchy A., Crowther D. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994 Mar 1;54(5):1298–1304. [PubMed] [Google Scholar]
  4. Boyle J. M., Mitchell E. L., Greaves M. J., Roberts S. A., Tricker K., Burt E., Varley J. M., Birch J. M., Scott D. Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families. Br J Cancer. 1998 Jun;77(12):2181–2192. doi: 10.1038/bjc.1998.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davison T. S., Yin P., Nie E., Kay C., Arrowsmith C. H. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome. Oncogene. 1998 Aug 6;17(5):651–656. doi: 10.1038/sj.onc.1202062. [DOI] [PubMed] [Google Scholar]
  6. Di Leonardo A., Linke S. P., Clarkin K., Wahl G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 1994 Nov 1;8(21):2540–2551. doi: 10.1101/gad.8.21.2540. [DOI] [PubMed] [Google Scholar]
  7. Dulić V., Kaufmann W. K., Wilson S. J., Tlsty T. D., Lees E., Harper J. W., Elledge S. J., Reed S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 1994 Mar 25;76(6):1013–1023. doi: 10.1016/0092-8674(94)90379-4. [DOI] [PubMed] [Google Scholar]
  8. Flaman J. M., Frebourg T., Moreau V., Charbonnier F., Martin C., Chappuis P., Sappino A. P., Limacher I. M., Bron L., Benhattar J. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3963–3967. doi: 10.1073/pnas.92.9.3963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jost C. A., Marin M. C., Kaelin W. G., Jr p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997 Sep 11;389(6647):191–194. doi: 10.1038/38298. [DOI] [PubMed] [Google Scholar]
  10. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997 Aug 22;90(4):809–819. doi: 10.1016/s0092-8674(00)80540-1. [DOI] [PubMed] [Google Scholar]
  11. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991 Dec 1;51(23 Pt 1):6304–6311. [PubMed] [Google Scholar]
  12. Kastan M. B., Zhan Q., el-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunkett B. S., Vogelstein B., Fornace A. J., Jr A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992 Nov 13;71(4):587–597. doi: 10.1016/0092-8674(92)90593-2. [DOI] [PubMed] [Google Scholar]
  13. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491–7495. doi: 10.1073/pnas.89.16.7491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Li C. Y., Nagasawa H., Dahlberg W. K., Little J. B. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene. 1995 Nov 2;11(9):1885–1892. [PubMed] [Google Scholar]
  15. Li F. P., Fraumeni J. F., Jr, Mulvihill J. J., Blattner W. A., Dreyfus M. G., Tucker M. A., Miller R. W. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988 Sep 15;48(18):5358–5362. [PubMed] [Google Scholar]
  16. Li F. P., Fraumeni J. F., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969 Oct;71(4):747–752. doi: 10.7326/0003-4819-71-4-747. [DOI] [PubMed] [Google Scholar]
  17. Little J. B. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature. 1968 Jun 15;218(5146):1064–1065. doi: 10.1038/2181064a0. [DOI] [PubMed] [Google Scholar]
  18. Little J. B. Irradiation of primary human amnion cell cultures: effects on DNA synthesis and progression through the cell cycle. Radiat Res. 1970 Dec;44(3):674–699. [PubMed] [Google Scholar]
  19. Little J. B., Nagasawa H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiat Res. 1985 Jan;101(1):81–93. [PubMed] [Google Scholar]
  20. Lomax M. E., Barnes D. M., Gilchrist R., Picksley S. M., Varley J. M., Camplejohn R. S. Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family. Oncogene. 1997 Apr 17;14(15):1869–1874. doi: 10.1038/sj.onc.1201133. [DOI] [PubMed] [Google Scholar]
  21. Mirzayans R., Aubin R. A., Bosnich W., Blattner W. A., Paterson M. C. Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Br J Cancer. 1995 Jun;71(6):1221–1230. doi: 10.1038/bjc.1995.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nagasawa H., Latt S. A., Lalande M. E., Little J. B. Effects of X-irradiation on cell-cycle progression, induction of chromosomal aberrations and cell killing in ataxia telangiectasia (AT) fibroblasts. Mutat Res. 1985 Jan-Feb;148(1-2):71–82. doi: 10.1016/0027-5107(85)90209-x. [DOI] [PubMed] [Google Scholar]
  23. Oren M. Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell. 1997 Sep 5;90(5):829–832. doi: 10.1016/s0092-8674(00)80347-5. [DOI] [PubMed] [Google Scholar]
  24. Schmale H., Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene. 1997 Sep;15(11):1363–1367. doi: 10.1038/sj.onc.1201500. [DOI] [PubMed] [Google Scholar]
  25. Tainsky M. A., Bischoff F. Z., Strong L. C. Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells. Cancer Metastasis Rev. 1995 Mar;14(1):43–48. doi: 10.1007/BF00690210. [DOI] [PubMed] [Google Scholar]
  26. Varley J. M., Chapman P., McGown G., Thorncroft M., White G. R., Greaves M. J., Scott D., Spreadborough A., Tricker K. J., Birch J. M. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Oncogene. 1998 Jun 25;16(25):3291–3298. doi: 10.1038/sj.onc.1201878. [DOI] [PubMed] [Google Scholar]
  27. Varley J. M., McGown G., Thorncroft M., Santibanez-Koref M. F., Kelsey A. M., Tricker K. J., Evans D. G., Birch J. M. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res. 1997 Aug 1;57(15):3245–3252. [PubMed] [Google Scholar]
  28. Westphal C. H., Schmaltz C., Rowan S., Elson A., Fisher D. E., Leder P. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res. 1997 May 1;57(9):1664–1667. [PubMed] [Google Scholar]
  29. Williams K. J., Boyle J. M., Birch J. M., Norton J. D., Scott D. Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition? Oncogene. 1997 Jan 23;14(3):277–282. doi: 10.1038/sj.onc.1200838. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES